Transarterial chemoembolization for advanced hepatocellular carcinoma without macrovascular invasion or extrahepatic metastasis: analysis of factors prognostic of clinical outcomes

Transarterial chemoembolization for advanced hepatocellular carcinoma without macrovascular invasion or extrahepatic metastasis: analysis of factors prognostic of clinical outcomes

ObjectivesTo evaluate the safety and efficacy of TACE and factors predicting survival in patients with advanced hepatocellular carcinoma (HCC) without macrovascular invasion (MVI) or extrahepatic spread (EHS).MethodsThis single-center retrospective study included 236 treatment-naïve patients who und...

Full description

Bibliographic Details
Main Authors:	Ji Hoon Kim, Jin Hyoung Kim, Hyun-Ki Yoon, Gi-Young Ko, Ji Hoon Shin, Dong Il Gwon, Heung-Kyu Ko, Hee Ho Chu, Seong Ho Kim, Gun Ha Kim, Yonghun Kim, Shakir Aljerdah
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Oncology
Subjects:	hepatocellular carcinoma chemoembolization ethiodized oil treatment outcome Barcelona clinic liver cancer (BCLC) staging
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1072922/full

Similar Items

Recent technical advances in conventional transarterial chemoembolization for hepatocellular carcinoma in Japan
by: Hiroki Higashihara, et al.
Published: (2021-10-01)

Value of computed tomography-based lipiodol retention pattern in the assessment of hepatocellular carcinoma complete response following conventional transarterial chemoembolization
by: Enas M. Sweed, et al.
Published: (2024-01-01)

Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment
by: Sujin Jin, et al.
Published: (2023-03-01)

Preoperative Balloon-Occluded Transcatheter Arterial Chemoembolization Followed by Surgical Resection: Pathological Evaluation of Necrosis
by: Jihoon Kim, et al.
Published: (2023-10-01)

Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety
by: Zi-shu Zhang, et al.
Published: (2019-11-01)

Chemoembolization for Single Large Hepatocellular Carcinoma with Preserved Liver Function: Analysis of Factors Predicting Clinical Outcomes in a 302 Patient Cohort
by: Gun Ha Kim, et al.
Published: (2021-08-01)

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
by: Sacco R, et al.
Published: (2017-07-01)

The priority of liver resection compared with transarterial chemoembolization in hepatocellular carcinoma at BCLC B1 stage: A single-center experience
by: Peng-Sheng Yi, et al.
Published: (2022-11-01)

Surgical Resection plus Intraoperative Radiofrequency Ablation versus Chemoembolization for the Treatment of Intermediate-Stage (BCLC B) Hepatocellular Carcinoma with Preserved Liver Function: A Propensity Score-Matched Analysis
by: Gun Ha Kim, et al.
Published: (2022-05-01)

Conventional or Drug-Eluting Beads? Randomized Controlled Study of Chemoembolization for Hepatocellular Carcinoma: JIVROSG-1302
by: Masafumi Ikeda, et al.
Published: (2022-06-01)

Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response
by: Marco Dioguardi Burgio, et al.
Published: (2019-11-01)

Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma
by: Hee Ho Chu, et al.
Published: (2021-06-01)

Local Recurrence following Radiological Complete Response in Patients Treated with Subsegmental Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
by: Dong Il Gwon, et al.
Published: (2023-10-01)

Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
by: David Sooik Kim, et al.
Published: (2021-12-01)

Initial Transarterial Chemoembolization (TACE) Using HepaSpheres 20–40 µm and Subsequent Lipiodol TACE in Patients with Hepatocellular Carcinoma > 5 cm
by: Su Min Cho, et al.
Published: (2021-04-01)

A Rare Case of Empyema Developed after Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Young Keun Sur, et al.
Published: (2015-01-01)

Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association
by: Yuri Cho, et al.
Published: (2023-09-01)

Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association
by: Yuri Cho, et al.
Published: (2023-07-01)

Outcome of transarterial radioembolization in patients with hepatocellular carcinoma as a first-line interventional therapy and after a previous transarterial chemoembolization
by: Julia Wagenpfeil, et al.
Published: (2024-02-01)

Transarterial chemoembolization using drug-eluting bead compared with radiofrequency ablation for treatment of single small hepatocellular carcinoma: a pilot non-randomized trial
by: Tae Hoon Kim, et al.
Published: (2021-09-01)

Beneficial Effect of Combining Radiotherapy and Transarterial Chemoembolization on Patient Survival in Hepatocellular Carcinomas and Macrovascular Invasion Treated with Sorafenib
by: Meng-Chuan Lu, et al.
Published: (2023-05-01)

Incidence and Risk Factors of Acute Ischemic Cholecystitis after Transarterial Chemoembolization: Correlation with Cone Beam CT Findings
by: Jong Yeong Kim, et al.
Published: (2024-03-01)

Hepatobronchial Fistula and Lung Abscess after Transarterial Chemoembolization
by: Kwanjoo Lee, et al.
Published: (2017-05-01)

Efficacy and Safety of Supplemental Transarterial Chemoembolization Through Extrahepatic Collateral Arteries with Drug-eluting Beads: Treatment for Unresectable Hepatocellular Carcinoma
by: Chiu SH, et al.
Published: (2020-11-01)

Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study
by: Su Jong Yu, et al.
Published: (2023-03-01)

Clinical outcomes of patients with a single hepatocellular carcinoma less than 5 cm treated with transarterial chemoembolization
by: Min Young Baek, et al.
Published: (2019-11-01)

Radiomics and machine learning based on preoperative MRI for predicting extrahepatic metastasis in hepatocellular carcinoma patients treated with transarterial chemoembolization
by: Gang Peng, et al.
Published: (2024-06-01)

A refined prediction model for survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
by: Hae Lim Lee, et al.
Published: (2024-03-01)

Etiopathogenetic Factors of Hepatocellular Carcinoma, Overall Survival, and Their Evolution over Time—Czech Tertiary Center Overview
by: Petr Hříbek, et al.
Published: (2022-08-01)

Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients
by: Sung Won Chung, et al.
Published: (2023-02-01)

Risk Factors for Liver Function Deterioration after Transarterial Chemoembolization Refractoriness in Child-Pugh Class A Hepatocellular Carcinoma Patients
by: Kang Hyun Park, et al.
Published: (2020-03-01)

Rupture of hepatocellular carcinoma after transcatheter arterial chemoembolization: A case report
by: Hye Hyeon Moon, et al.
Published: (2021-01-01)

Prognostic Values of Inflammation-Based Scores and Fibrosis Markers in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
by: Eun Ju Cho, et al.
Published: (2022-05-01)

Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
by: Young Eun Chon, et al.
Published: (2019-04-01)

Gallbladder actinomycosis: Is it a complication after radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma?
by: Han Hyung, et al.
Published: (2011-06-01)

Gallbladder Perforation after Transarterial Chemoembolization in a Patient with a Huge Hepatocellular Carcinoma
by: Min Young Son, et al.
Published: (2020-07-01)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
by: Zhang W, et al.
Published: (2021-07-01)

Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma
by: Kil Hyo Park, et al.
Published: (2015-06-01)

Transarterial Chemoembolization in Hepatocellular Carcinoma, Albanian Experience.
by: Ilirian Laçi, et al.
Published: (2022-07-01)

Transarterial chemoembolization for patients with metastatic uveal melanoma in the liver
by: B. I. Dolgushin, et al.
Published: (2016-09-01)